Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Zesiewicz TA, Wilmot G, Kuo SH, Perlman S, Greenstein PE, Ying SH, Ashizawa T, Subramony SH, Schmahmann JD, Figueroa KP, Mizusawa H, Schöls L, Shaw JD, Dubinsky RM, Armstrong MJ, Gronseth GS, Sullivan KL.

Neurology. 2018 Mar 6;90(10):464-471. doi: 10.1212/WNL.0000000000005055. Epub 2018 Feb 9.

2.

Author response: Practice guideline summary: Reducing brain injury following cardiopulmonary resuscitation: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Geocadin RG, Wijdicks E, Dubinsky RM, Ornato JP, Torbey MT, Suarez JI.

Neurology. 2017 Nov 28;89(22):2302-2303. doi: 10.1212/WNL.0000000000004697. No abstract available.

PMID:
29180579
3.

Practice guideline summary: Reducing brain injury following cardiopulmonary resuscitation: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Geocadin RG, Wijdicks E, Armstrong MJ, Damian M, Mayer SA, Ornato JP, Rabinstein A, Suarez JI, Torbey MT, Dubinsky RM, Lazarou J.

Neurology. 2017 May 30;88(22):2141-2149. doi: 10.1212/WNL.0000000000003966. Epub 2017 May 10.

4.

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.

McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS Jr, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M; Huntington Study Group 2CARE Investigators and Coordinators.

Neurology. 2017 Jan 10;88(2):152-159. doi: 10.1212/WNL.0000000000003478. Epub 2016 Dec 2.

5.

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

Huntington Study Group, Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F Jr, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E.

JAMA. 2016 Jul 5;316(1):40-50. doi: 10.1001/jama.2016.8655.

6.

Practical steps for implementing quality measurement in practice.

Wang D, Schierman BA, Cheng EM, Sanders AE, Dubinsky RM.

Neurol Clin Pract. 2014 Oct;4(5):447-453.

7.

Quality improvement in neurology: Distal symmetric polyneuropathy quality measures.

England JD, Franklin G, Gjorvad G, Swain-Eng R, Brannagan TH 3rd, David WS, Dubinsky RM, Smith BE.

Neurology. 2014 May 13;82(19):1745-8. doi: 10.1212/WNL.0000000000000397. Epub 2014 Apr 2.

8.

Is there an increased risk of hip fracture in multiple sclerosis? Analysis of the Nationwide Inpatient Sample.

Bhattacharya RK, Vaishnav N, Dubinsky RM.

J Multidiscip Healthc. 2014 Feb 13;7:119-22. doi: 10.2147/JMDH.S54786. eCollection 2014.

9.

Is there an increased risk of hip fracture in Parkinson's disease? A nationwide inpatient sample.

Bhattacharya RK, Dubinsky RM, Lai SM, Dubinsky H.

Mov Disord. 2012 Sep 15;27(11):1440-3. doi: 10.1002/mds.25073. Epub 2012 Jun 28.

PMID:
22744727
10.
11.

What is driving the legal interest in hepatic encephalopathy?

Bajaj JS, Stein AC, Dubinsky RM.

Clin Gastroenterol Hepatol. 2011 Feb;9(2):97-8. doi: 10.1016/j.cgh.2010.10.031. Epub 2010 Nov 9. No abstract available.

PMID:
21070873
12.
13.

Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Iverson DJ, Gronseth GS, Reger MA, Classen S, Dubinsky RM, Rizzo M; Quality Standards Subcomittee of the American Academy of Neurology.

Neurology. 2010 Apr 20;74(16):1316-24. doi: 10.1212/WNL.0b013e3181da3b0f. Epub 2010 Apr 12. Review.

15.

Minimal hepatic encephalopathy and driving.

Dubinsky RM, Stein AC.

Hepatology. 2009 Oct;50(4):1007-8. doi: 10.1002/hep.23269. No abstract available.

PMID:
19787810
16.

Invited article: Neurology and quality improvement: an introduction.

Bever CT, Holloway RG, Iverson DJ, Dubinsky RM, Richardson RM, Sheffield JK, Wang DZ, Franklin GM, Miyasaki JM, Tonn ST, Stevens JC.

Neurology. 2008 Apr 29;70(18):1636-40. doi: 10.1212/01.wnl.0000310989.84987.88. No abstract available.

PMID:
18443315
17.

Reassessment: neuroimaging in the emergency patient presenting with seizure (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Harden CL, Huff JS, Schwartz TH, Dubinsky RM, Zimmerman RD, Weinstein S, Foltin JC, Theodore WH; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Neurology. 2007 Oct 30;69(18):1772-80.

PMID:
17967993
18.

Alzheimer's disease and essential tremor finally meet.

Elble RJ, Dubinsky RM, Ala T.

Mov Disord. 2007 Aug 15;22(11):1525-7. No abstract available.

PMID:
17557351
19.
20.

No going home for hospitalized Huntington's disease patients.

Dubinsky RM.

Mov Disord. 2005 Oct;20(10):1316-22.

PMID:
16001414
21.

Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology.

Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H; Quality Standards Subcommittee of the American Academy of Neurology.

Neurology. 2004 Sep 28;63(6):959-65. Review.

PMID:
15452284
22.

A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor.

Brin MF, Lyons KE, Doucette J, Adler CH, Caviness JN, Comella CL, Dubinsky RM, Friedman JH, Manyam BV, Matsumoto JY, Pullman SL, Rajput AH, Sethi KD, Tanner C, Koller WC.

Neurology. 2001 Jun 12;56(11):1523-8.

PMID:
11402109
23.

Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL.

Neurology. 2001 May 8;56(9):1154-66.

PMID:
11342679
25.

Botulinum toxin treatment of essential head tremor.

Pahwa R, Busenbark K, Swanson-Hyland EF, Dubinsky RM, Hubble JP, Gray C, Koller WC.

Neurology. 1995 Apr;45(4):822-4.

PMID:
7723978
26.

Comparison of glucose metabolism and cerebral blood flow during cortical motor activation.

Hallett M, Dubinsky RM, Zeffiro T, Bierner SM.

J Neuroimaging. 1994 Jan;4(1):1-5.

PMID:
8136573
27.

Essential tremor and dystonia.

Dubinsky RM, Gray CS, Koller WC.

Neurology. 1993 Nov;43(11):2382-4.

PMID:
8232962
28.

Glucose metabolism in the brain of patients with essential tremor.

Hallett M, Dubinsky RM.

J Neurol Sci. 1993 Jan;114(1):45-8.

PMID:
8433096
29.

Driving in Alzheimer's disease.

Dubinsky RM, Williamson A, Gray CS, Glatt SL.

J Am Geriatr Soc. 1992 Nov;40(11):1112-6.

PMID:
1401695
30.

Electromyographic guidance of botulinum toxin treatment in cervical dystonia.

Dubinsky RM, Gray CS, Vetere-Overfield B, Koller WC.

Clin Neuropharmacol. 1991 Jun;14(3):262-7.

PMID:
2070367
31.

Increased glucose metabolism in the medulla of patients with palatal myoclonus.

Dubinsky RM, Hallett M, Di Chiro G, Fulham M, Schwankhaus J.

Neurology. 1991 Apr;41(4):557-62.

PMID:
2011257
32.

Driving in Parkinson's disease.

Dubinsky RM, Gray C, Husted D, Busenbark K, Vetere-Overfield B, Wiltfong D, Parrish D, Koller WC.

Neurology. 1991 Apr;41(4):517-20.

PMID:
2011249
33.

Computed tomography, magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in multiple system atrophy and pure autonomic failure.

Fulham MJ, Dubinsky RM, Polinsky RJ, Brooks RA, Brown RT, Curras MT, Baser S, Hallett M, Di Chiro G.

Clin Auton Res. 1991 Mar;1(1):27-36.

PMID:
1821662
34.

Congenital mirror movements. Abnormal organization of motor pathways in two patients.

Cohen LG, Meer J, Tarkka I, Bierner S, Leiderman DB, Dubinsky RM, Sanes JN, Jabbari B, Branscum B, Hallett M.

Brain. 1991 Feb;114 ( Pt 1B):381-403.

PMID:
2004248
35.

A double-blind trial of isoniazid for essential tremor and other action tremors.

Hallett M, Ravits J, Dubinsky RM, Gillespie MM, Moinfar A.

Mov Disord. 1991;6(3):253-6.

PMID:
1681430
36.

Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC).

Dubinsky RM, Yarchoan R, Dalakas M, Broder S.

Muscle Nerve. 1989 Oct;12(10):856-60.

PMID:
2558314
37.

Regional brain glucose metabolism in neuroacanthocytosis.

Dubinsky RM, Hallett M, Levey R, Di Chiro G.

Neurology. 1989 Sep;39(9):1253-5.

PMID:
2788833
38.

Hemiballismus: study of a case using positron emission tomography with 18fluoro-2-deoxyglucose.

Dubinsky RM, Greenberg M, Di Chiro G, Baker M, Hallett M.

Mov Disord. 1989;4(4):310-9.

PMID:
2811890
39.

Follow-up of neuropathy from 2',3'-dideoxycytidine.

Dubinsky RM, Dalakas M, Yarchoan R, Broder S.

Lancet. 1988 Apr 9;1(8589):832. No abstract available.

PMID:
2895352
40.

Palatal myoclonus and facial involvement in other types of myoclonus.

Dubinsky RM, Hallett M.

Adv Neurol. 1988;49:263-78. Review. No abstract available.

PMID:
3125725
41.

Progressive supranuclear palsy and a multi-infarct state.

Dubinsky RM, Jankovic J.

Neurology. 1987 Apr;37(4):570-6.

PMID:
3561771

Supplemental Content

Loading ...
Support Center